Corvus Pharmaceuticals, Inc.
CRVS
$6.93
-$0.32-4.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 57.49% | 99.80% | 91.40% | 29.48% | 27.63% |
| Total Receivables | 112.30% | 291.38% | 242.86% | 342.00% | 258.82% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -33.93% | 105.26% | 25.33% | -24.37% | -11.11% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 102.33% | 30.38% | 376.15% | 82.09% | 32.19% |
| Total Current Assets | 57.03% | 99.08% | 94.62% | 29.69% | 27.30% |
|
|
|||||
| Total Current Assets | 57.03% | 99.08% | 94.62% | 29.69% | 27.30% |
| Net Property, Plant & Equipment | 63.77% | 16.88% | -4.12% | -73.03% | -61.21% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 385.27% | 606.74% | 610.11% | 183.15% | 0.00% |
| Total Assets | 38.57% | 48.28% | 51.27% | 13.23% | 11.23% |
|
|
|||||
| Total Accounts Payable | 158.62% | -18.71% | 69.31% | 33.40% | -42.18% |
| Total Accrued Expenses | 14.56% | -8.14% | -7.76% | -11.26% | -5.78% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -49.29% | -69.33% | -86.54% | -73.50% | -46.11% |
| Total Finance Division Other Current Liabilities | -95.29% | 2,177.65% | 11,817.96% | 15,306.87% | 5,263.50% |
| Total Other Current Liabilities | -95.29% | 2,177.65% | 11,817.96% | 15,306.87% | 5,263.50% |
| Total Current Liabilities | -36.22% | 38.08% | 415.39% | 535.79% | 69.70% |
|
|
|||||
| Total Current Liabilities | -36.22% | 38.08% | 415.39% | 535.79% | 69.70% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -30.76% | 50.49% | 429.03% | 506.38% | 55.82% |
|
|
|||||
| Common Stock & APIC | 18.61% | 15.29% | 15.09% | 6.49% | 6.53% |
| Retained Earnings | -13.09% | -12.16% | -18.61% | -17.32% | -7.02% |
| Treasury Stock & Other | 15.28% | 1.65% | -33.20% | 48.86% | 0.95% |
| Total Common Equity | 56.62% | 47.84% | -15.81% | -71.98% | 3.52% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 56.62% | 47.84% | -15.81% | -71.98% | 3.52% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 56.62% | 47.84% | -15.81% | -71.98% | 3.52% |
|
|
|||||